It’s time for the FDA to remove the outdated and misleading boxed warning label on local vaginal estrogen. 75 million women in menopause are being held back by outdated and misleading FDA warnings on local vaginal estrogen—a proven, safe, and effective treatment for GSM symptoms like tissue thinning, painful sex, and recurrent UTIs. Despite overwhelming support from scientific studies, this …